» Articles » PMID: 35618112

EEG Asymmetry and Cognitive Testing in MCI Identification

Overview
Publisher Elsevier
Specialty Psychiatry
Date 2022 May 26
PMID 35618112
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Finding the baseline resting-state EEG markers for early identification of cognitive decline can contribute to the identification of individuals at risk of further change. Potential applications include identifying participants for clinical trials, early treatment, and evaluation of treatment, accessible even from a community setting.

Methods: Analyses were completed on a sample of 99 (ages 60-90) consensus-diagnosed, community-dwelling African Americans (58 cognitively typical/HC, and 41 mildly cognitively impaired/MCI), who were recruited from the Michigan Alzheimer's Disease Research Center (MADRC) and the Wayne State University Institute of Gerontology. In addition to neuropsychological testing with CogState and Toolbox computerized batteries, resting-state EEGs (rsEEG, eyes closed) were acquired before and after participants were engaged in a visual motion direction discrimination task. rsEEG frontal alpha asymmetry (FAA) and frontal beta asymmetry (FBA) were calculated.

Results: FAA showed no difference across groups for the pre-task resting state. FBA was significantly different between groups, with more asymmetric frontal beta in MCI. Both physiological indices, however, along with computerized neuropsychological tests were significant predictors in logistic regression classification of MCI vs. control participants.

Conclusion: rsEEG asymmetries can contribute significantly to successful discrimination of older persons with MCI from those without, over and above cognitive testing, alone.

Citing Articles

Resting-State EEG Power Spectral Density Analysis Between Healthy and Cognitively Impaired Subjects.

Walters K, Shukla R, Kumar V, Schueren S, Yadav H, Schilaty N Brain Sci. 2025; 15(2).

PMID: 40002506 PMC: 11853412. DOI: 10.3390/brainsci15020173.


Characteristics of the top 100 cited electroencephalography articles on aging: a bibliometric analysis.

Pu Y, Tian P, Huang Z Am J Transl Res. 2024; 16(5):1749-1756.

PMID: 38883376 PMC: 11170590. DOI: 10.62347/CCTI1306.


Classification of cognitive impairment in older adults based on brain functional state measurement data via hierarchical clustering analysis.

Liu Y, Wang N, Su X, Zhao T, Zhang J, Geng Y Front Aging Neurosci. 2024; 15:1198481.

PMID: 38161594 PMC: 10757366. DOI: 10.3389/fnagi.2023.1198481.


Synergy through integration of digital cognitive tests and wearable devices for mild cognitive impairment screening.

Li A, Li J, Zhang D, Wu W, Zhao J, Qiang Y Front Hum Neurosci. 2023; 17:1183457.

PMID: 37144160 PMC: 10151757. DOI: 10.3389/fnhum.2023.1183457.


Exploratory Study on Chemosensory Event-Related Potentials in Long COVID-19 and Mild Cognitive Impairment: A Common Pathway?.

Invitto S, Boscolo-Rizzo P, Fantin F, Bonifati D, de Filippis C, Emanuelli E Bioengineering (Basel). 2023; 10(3).

PMID: 36978767 PMC: 10045951. DOI: 10.3390/bioengineering10030376.

References
1.
Harmon-Jones E, Gable P, Peterson C . The role of asymmetric frontal cortical activity in emotion-related phenomena: a review and update. Biol Psychol. 2009; 84(3):451-62. DOI: 10.1016/j.biopsycho.2009.08.010. View

2.
Kayser J, Tenke C . On the benefits of using surface Laplacian (current source density) methodology in electrophysiology. Int J Psychophysiol. 2015; 97(3):171-3. PMC: 4610715. DOI: 10.1016/j.ijpsycho.2015.06.001. View

3.
Harmon-Jones E, Allen J . Behavioral activation sensitivity and resting frontal EEG asymmetry: covariation of putative indicators related to risk for mood disorders. J Abnorm Psychol. 1997; 106(1):159-63. DOI: 10.1037//0021-843x.106.1.159. View

4.
Finnigan S, Robertson I . Resting EEG theta power correlates with cognitive performance in healthy older adults. Psychophysiology. 2011; 48(8):1083-7. DOI: 10.1111/j.1469-8986.2010.01173.x. View

5.
Clark L, Watkins L, Pina I, Elmer M, Akinboboye O, Gorham M . Increasing Diversity in Clinical Trials: Overcoming Critical Barriers. Curr Probl Cardiol. 2018; 44(5):148-172. DOI: 10.1016/j.cpcardiol.2018.11.002. View